Enilconazole

Enilconazole Market Outlook

The global Enilconazole market is anticipated to reach approximately USD 150 million by 2035, growing at a CAGR of around 5.3% during the forecast period of 2025 to 2035. This growth can be attributed to the increasing demand for effective antifungal agents in various applications such as agriculture, veterinary medicine, and pharmaceuticals. Rising awareness about the effects of fungal infections on crops and livestock further drives the market, as stakeholders seek to improve crop yield and maintain livestock health. Furthermore, innovations in formulation methodologies and increasing investment in research and development are expected to bolster market growth. The growing prevalence of fungal diseases and the subsequent need for effective treatment solutions continue to be significant factors influencing the Enilconazole market.

Growth Factor of the Market

One of the primary growth factors for the Enilconazole market is the escalating incidence of fungal diseases affecting both crops and animals. The agricultural sector, in particular, is witnessing an upsurge in demand for advanced fungicides to safeguard crops from destructive fungi, thereby ensuring food security. The veterinary sector is also experiencing a heightened focus on animal health, which drives the need for reliable antifungal medications to manage infections in livestock. Additionally, ongoing research and development initiatives aimed at enhancing the efficacy and safety of Enilconazole formulations are likely to present lucrative opportunities for market expansion. The increasing adoption of integrated pest management practices is another factor contributing to the market's growth, as farmers and veterinarians seek sustainable and effective solutions to combat fungal threats. Moreover, favorable government regulations and support for innovative agricultural practices are further propelling the demand for Enilconazole in various applications.

Key Highlights of the Market

• Steady growth projected at a CAGR of 5.3% from 2025 to 2035.
• Significant demand in agricultural sector due to rising fungal diseases.
• Increasing awareness about livestock health and effective antifungal treatments.
• Innovations in formulation methodologies enhancing product safety and efficacy.
• Expanding distribution channels, including online platforms, boosting market accessibility.

By Product Type

Liquid Formulation:

Liquid formulations of Enilconazole are among the most widely used due to their ease of application and quick action against fungal infections. These formulations are particularly preferred in agriculture, where they can be sprayed directly onto crops to provide immediate protection against fungal pathogens. They offer excellent distribution and penetration properties, making them highly effective for both preventative and curative treatments. The liquid form also enables better mixing with other agrochemicals, enhancing the overall effectiveness of pest management strategies. As a result, the liquid formulation segment is expected to hold a significant share in the Enilconazole market, driven by its versatility and effectiveness in various applications.

Powder Formulation:

Powder formulations of Enilconazole are gaining traction in both agricultural and veterinary applications due to their long shelf-life and stability. These formulations are typically used in situations where moisture could affect the efficacy of the product, making them ideal for dry climates or storage conditions. They can be mixed with water or used in dry applications, allowing for greater flexibility in usage. Additionally, powder formulations are often favored in veterinary medicine for treating fungal infections in animals, due to their easy administration and precise dosage capabilities. The increasing use of powder formulations in specialized applications is expected to contribute significantly to the overall growth of the Enilconazole market.

Gel Formulation:

Gel formulations of Enilconazole offer unique benefits, particularly in veterinary applications, where they are used for localized treatment of fungal infections. The gel consistency allows for easy application on affected areas, ensuring targeted delivery of the active ingredient. These formulations can also enhance the bioavailability of Enilconazole, improving treatment outcomes for patients. The ease of application and reduced risk of spillage make gel formulations highly desirable among veterinarians and animal caretakers. As the demand for effective localized treatments continues to rise, the gel formulation segment is expected to expand, bolstering the overall Enilconazole market.

Spray Formulation:

Spray formulations are particularly popular in agricultural sectors due to their ability to cover large areas efficiently. These formulations allow for quick and uniform distribution of Enilconazole, ensuring that crops receive adequate protection against fungal infestations. The convenience of spray applications, coupled with advancements in spraying technologies, has made this formulation type highly effective for large-scale agricultural practices. Additionally, the ease of use associated with spray formulations encourages adoption among farmers, further driving market growth. With increasing recognition of the importance of timely and effective fungal management in agriculture, the spray formulation segment is anticipated to experience significant growth in the Enilconazole market.

Other Formulations:

Aside from the common formulations mentioned, there are various other formulations of Enilconazole that cater to specific needs within the market. These may include emulsifiable concentrates, granular formulations, or advanced delivery systems designed for enhanced efficacy or specialized applications. The flexibility offered by these alternative formulations allows manufacturers to cater to diverse market requirements and consumer preferences. As the demand for customized solutions increases, the segment of other formulations is expected to witness steady growth, adding to the overall dynamics of the Enilconazole market. Manufacturers that focus on innovation in this segment will likely capitalize on emerging market opportunities.

By Application

Agriculture:

In the agricultural sector, Enilconazole is predominantly used for the effective management of fungal diseases that can severely impact crop yield and quality. Its broad-spectrum antifungal properties make it an essential tool for farmers seeking to protect their crops from common pathogens such as powdery mildew and root rot. The increasing global population and the resultant demand for food have created a pressing need for enhanced agricultural productivity, thereby driving the adoption of Enilconazole in farming practices. As awareness about sustainable agricultural practices rises, the use of Enilconazole as part of integrated pest management strategies is gaining traction, further solidifying its position in the market.

Veterinary:

The veterinary application of Enilconazole is crucial for the treatment of fungal infections in animals. This segment is driven by the growing recognition of animal health and well-being, as well as the increasing instances of fungal infections among livestock and pets. Enilconazole plays a significant role in treating a range of fungal diseases affecting various species, including cattle, dogs, and cats. The rising trend of pet ownership and the emphasis on maintaining livestock health contribute to the growing demand for effective veterinary antifungal agents. Consequently, the veterinary application segment is expected to see a robust increase in market share as stakeholders prioritize animal health.

Pharmaceutical:

In the pharmaceutical sector, Enilconazole is utilized for its antifungal properties in various formulations aimed at treating human fungal infections. The rising incidence of fungal infections, particularly among immunocompromised patients, has increased the demand for effective antifungal medications. Enilconazole’s proven efficacy in combating fungal pathogens positions it as a vital component in pharmaceutical formulations. Ongoing research into the potential for new drug formulations and the growing focus on emerging fungal threats further supports the expansion of this segment. As the healthcare landscape continues to evolve, the pharmaceutical application of Enilconazole is poised for sustained growth.

Other Applications:

Beyond agriculture, veterinary, and pharmaceutical uses, Enilconazole finds applications in various other sectors including household products and industrial uses. For instance, it can be employed in disinfectants and sanitizers, contributing to overall hygiene and health standards in residential and commercial spaces. The versatility of Enilconazole enables manufacturers to explore additional application areas, which can significantly broaden its market footprint. As the demand for multifunctional antifungal agents rises, the segment of other applications is likely to gain traction, providing new opportunities for growth in the Enilconazole market.

By Distribution Channel

Online Stores:

The online distribution channel for Enilconazole products has gained immense popularity due to the convenience it offers consumers. E-commerce platforms allow farmers, veterinarians, and pharmaceutical companies to purchase necessary formulations with ease, without the constraints of physical store locations. As digital penetration continues to rise globally, more stakeholders are turning to online stores for their procurement needs. This shift is reflected in the increase in market share for online sales, as they provide access to a wider range of products and often better pricing. The growth of online shopping is expected to significantly contribute to the overall expansion of the Enilconazole market in the coming years.

Agrochemical Stores:

Agrochemical stores have been a traditional distribution channel for Enilconazole and continue to play a vital role in the market. Farmers and agricultural professionals often prefer purchasing antifungal agents from specialized agrochemical supply stores that offer expert advice and product knowledge. These stores typically stock a variety of formulations, enabling customers to choose products according to their specific needs. The established relationship between customers and local agrochemical suppliers plays a crucial role in ensuring customer loyalty and repeat business. As the demand for effective antifungal solutions in agriculture grows, agrochemical stores are expected to maintain their significance in the Enilconazole market.

Veterinary Clinics:

Veterinary clinics represent another important distribution channel for Enilconazole, particularly in the context of its use for treating fungal infections in animals. Veterinarians often prescribe specific formulations based on their experience and the unique needs of their patients. The presence of Enilconazole in veterinary clinics provides pet owners and farmers easy access to effective antifungal treatments. The trust that pet owners place in their veterinarians further drives sales through this channel. With the growing emphasis on animal health and welfare, this distribution channel is anticipated to witness steady growth and play a significant role in the overall Enilconazole market.

Others:

Other distribution channels for Enilconazole include wholesale distributors, agricultural cooperatives, and regional suppliers. These channels serve as intermediaries that bridge the gap between manufacturers and end-users, ensuring that products are widely available and accessible. The presence of wholesale distributors allows for bulk purchasing, which is particularly beneficial for large farming operations and veterinary clinics that require consistent supplies of antifungal agents. Furthermore, regional suppliers often have a deep understanding of local market needs, enabling them to tailor their offerings accordingly. As the market continues to evolve, the significance of these other distribution channels is expected to grow, complementing the more traditional retail avenues.

By Ingredient Type

Enilconazole 95% TC:

Enilconazole with a concentration of 95% technical grade (TC) is a highly concentrated formulation primarily used by manufacturers and large agricultural producers. This ingredient type serves as the active basis for various formulations, allowing for further dilution or incorporation into different products according to specific application needs. The high potency of Enilconazole 95% TC ensures that it effectively combats a wide range of fungal pathogens, making it an essential ingredient for both agricultural and veterinary applications. As the agricultural sector continues to seek out effective solutions for fungal diseases, the demand for high-quality technical-grade Enilconazole is expected to rise significantly.

Enilconazole 10% EC:

The 10% emulsifiable concentrate (EC) formulation of Enilconazole is favored for its ease of use and effective antifungal action. This ingredient type is particularly popular among farmers and agricultural professionals who require a ready-to-use solution that can be easily mixed with water for application purposes. The emulsion properties allow for better dispersion and adherence on plant surfaces, optimizing the efficacy of the treatment. Given the increasing focus on sustainable agricultural practices, the 10% EC formulation is expected to witness steady demand as farmers look for reliable solutions to manage fungal threats efficiently.

Enilconazole 20% EW:

The 20% emulsifiable water formulation (EW) of Enilconazole is designed to provide an effective balance between potency and safety for agricultural applications. This formulation offers enhanced performance against fungal pathogens while minimizing potential risks to non-target organisms. Farmers appreciate the effective solution that is easy to handle and apply in field settings. The 20% EW formulation is particularly effective at preventing the development of resistance among fungal populations, making it a preferred choice in integrated pest management strategies. As agricultural practices evolve, the acceptance and preference for this formulation are likely to increase, contributing positively to market growth.

Enilconazole 50% WP:

The 50% wettable powder (WP) formulation of Enilconazole is widely used in various agricultural settings due to its versatility and effectiveness in controlling fungal diseases. This ingredient type can be easily suspended in water, making it suitable for foliar applications on crops. Wettable powders typically provide long-lasting residual effects, ensuring prolonged protection against fungal infections. Additionally, the formulation allows for high precision in dosage, which is essential for effective disease management. As the need for reliable fungicides increases, the demand for the 50% WP formulation is expected to remain strong in the Enilconazole market.

Other Concentrations:

In addition to the standard concentrations, various other formulations of Enilconazole exist that cater to specific application needs. These may include lower or higher concentration formulations designed for niche markets or particular environmental conditions. The ability to customize concentration levels allows manufacturers to meet diverse customer requirements and respond to varying regulatory standards across regions. The continued innovation in formulation chemistry will likely lead to the development of new concentration types that can address emerging challenges in fungal management. As such, the segment of other concentrations is expected to contribute positively to the overall dynamics of the Enilconazole market.

By Region

The North American Enilconazole market is projected to showcase robust growth, primarily driven by the region's emphasis on advanced agricultural practices and strong veterinary care standards. The increasing adoption of innovative fungicides in agriculture, coupled with rising awareness about animal health, contributes significantly to market expansion. The North American market is expected to reach approximately USD 45 million by 2035, capturing a significant share of the global market. Additionally, favorable regulations and support for effective agrochemical solutions are likely to accelerate growth in this region, confirming its position as a leader in the Enilconazole market.

Europe is also witnessing substantial growth in the Enilconazole market, with predictions of reaching USD 40 million by 2035. The focus on sustainable agricultural practices and integrated pest management is driving demand for effective antifungal agents across the region. The increasing prevalence of fungal diseases among crops and livestock underscores the need for reliable treatment solutions. Furthermore, European regulatory standards supporting the use of environmentally friendly agrochemicals contribute to the ongoing growth of the market in this region. The CAGR for the European Enilconazole market is projected to be around 4.9%, reflecting a steady rise in adoption rates across various applications.

Opportunities

The Enilconazole market presents numerous opportunities for growth as stakeholders increasingly recognize the importance of effective fungicides in agriculture and veterinary medicine. One of the most promising avenues lies in expanding research and development efforts aimed at creating innovative formulations tailored to specific market needs. As the global agricultural landscape evolves, there is a growing demand for eco-friendly and sustainable pest management solutions. Therefore, manufacturers that invest in developing advanced formulations with lower environmental impact will have the potential to capture significant market share. Additionally, collaborations with agricultural cooperatives and veterinary organizations can open new channels for distribution and adoption, further enhancing growth prospects in this sector.

Another opportunity for the Enilconazole market stems from the increasing adoption of digital solutions and precision agriculture technologies. Farmers are becoming more reliant on data-driven approaches to manage their crops effectively, which can integrate Enilconazole applications into their pest management strategies. By leveraging technology to optimize application timing and dosage, farmers can enhance the efficacy and efficiency of Enilconazole, leading to improved crop yields and reduced fungal threats. Furthermore, the potential for entering emerging markets, particularly in Asia Pacific and Latin America, offers additional avenues for growth as these regions ramp up their agricultural practices and seek effective solutions to combat fungal diseases. By capitalizing on these trends, stakeholders in the Enilconazole market can unlock new growth opportunities while addressing the evolving needs of their customers.

Threats

Despite the significant growth potential, the Enilconazole market faces several threats that could hinder its expansion. One of the primary concerns is the increasing regulation surrounding agrochemicals globally. Stricter regulatory frameworks aimed at ensuring environmental safety and public health may lead to challenges in product registration and market entry for new formulations. Companies must navigate complex regulatory processes, which can be time-consuming and costly, potentially slowing market growth. Additionally, the rising awareness of sustainability and environmental concerns among consumers can lead to backlash against chemical-based fungicides, resulting in shifts toward organic alternatives. This transition may impact demand for Enilconazole, posing a challenge for manufacturers who need to adapt to changing consumer preferences.

Another significant threat to the Enilconazole market is the emergence of fungal resistance. The repeated use of the same antifungal agents can lead to the development of resistant fungal strains, undermining the efficacy of existing treatments. As resistance becomes more prevalent, farmers and veterinarians may seek alternative solutions, reducing reliance on Enilconazole. In response to this challenge, companies must invest in research and development to innovate new formulations and strategies that can overcome resistance issues while maintaining efficacy. Failure to address these threats could impede growth and market share in the competitive landscape of antifungal agents.

Competitor Outlook

• BASF SE
• Syngenta AG
• Corteva Agriscience
• FMC Corporation
• Bayer CropScience AG
• Adama Agricultural Solutions Ltd.
• UPL Limited
• Nufarm Limited
• Zhejiang Yongnong Chem. Ind. Co., Ltd.
• Hefei Great Chemical Group Co., Ltd.
• Shijiazhuang Wuyiling Chemical Co., Ltd.
• Jiangsu Tianrong Chemical Co., Ltd.
• Guangzhou Guanghua Chemical Co., Ltd.
• Wuhan Huazhong Chemical Co., Ltd.
• Shenzhen Jinhui Chemical Co., Ltd.

The competitive landscape of the Enilconazole market is characterized by a blend of established agrochemical companies and emerging players vying for market share. Major players such as BASF SE and Syngenta AG have a solid foundation in the agrochemical industry, leveraging their extensive distribution networks and research capabilities to enhance the development and marketing of Enilconazole products. These companies focus on innovation, reliability, and sustainability in their product offerings to meet the evolving needs of customers. The competitive environment is influenced by the drive for continuous improvement in formulations, as well as the need to navigate regulatory frameworks while maintaining product efficacy.

Companies such as Corteva Agriscience and FMC Corporation are also making substantial strides in the Enilconazole segment, focusing on R&D to develop advanced formulations that address specific agricultural challenges. Their commitment to sustainability and the integration of digital technologies into their business models are key differentiators in the market. Additionally, emerging players like Zhejiang Yongnong Chem. Ind. Co., Ltd. are gaining traction by offering cost-effective alternatives and targeting niche markets within the Enilconazole space. The competitive landscape is likely to become increasingly dynamic as these companies strive to establish their presence and expand their product portfolios.

As the Enilconazole market evolves, strategic partnerships and collaborations among companies will play a pivotal role in driving growth. Partnerships with research institutions and local agriculture stakeholders can accelerate innovations and enhance product development efforts. Key players are also expected to invest in marketing initiatives focusing on the benefits of Enilconazole in integrated pest management strategies, thereby enhancing awareness among end-users. Moreover, leveraging digital platforms to improve customer engagement and streamline the purchasing process is becoming increasingly important in the competitive landscape. As these trends continue to unfold, the Enilconazole market is poised for sustained growth, driven by both established companies and emerging competitors.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Syngenta AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 UPL Limited
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Nufarm Limited
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 FMC Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Corteva Agriscience
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bayer CropScience AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Adama Agricultural Solutions Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Wuhan Huazhong Chemical Co., Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Shenzhen Jinhui Chemical Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Jiangsu Tianrong Chemical Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hefei Great Chemical Group Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Guangzhou Guanghua Chemical Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Zhejiang Yongnong Chem. Ind. Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shijiazhuang Wuyiling Chemical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Enilconazole Market, By Application
    • 6.1.1 Agriculture
    • 6.1.2 Veterinary
    • 6.1.3 Pharmaceutical
    • 6.1.4 Other Applications
  • 6.2 Enilconazole Market, By Product Type
    • 6.2.1 Liquid Formulation
    • 6.2.2 Powder Formulation
    • 6.2.3 Gel Formulation
    • 6.2.4 Spray Formulation
    • 6.2.5 Other Formulations
  • 6.3 Enilconazole Market, By Ingredient Type
    • 6.3.1 Enilconazole 95% TC
    • 6.3.2 Enilconazole 10% EC
    • 6.3.3 Enilconazole 20% EW
    • 6.3.4 Enilconazole 50% WP
    • 6.3.5 Other Concentrations
  • 6.4 Enilconazole Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Agrochemical Stores
    • 6.4.3 Veterinary Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Enilconazole Market by Region
  • 10.3 Asia Pacific - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 India
      • 10.3.1.2 China
      • 10.3.1.3 Japan
      • 10.3.1.4 South Korea
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Enilconazole market is categorized based on

By Product Type

• Liquid Formulation
• Powder Formulation
• Gel Formulation
• Spray Formulation
• Other Formulations

By Application

• Agriculture
• Veterinary
• Pharmaceutical
• Other Applications

By Distribution Channel

• Online Stores
• Agrochemical Stores
• Veterinary Clinics
• Others

By Ingredient Type

• Enilconazole 95% TC
• Enilconazole 10% EC
• Enilconazole 20% EW
• Enilconazole 50% WP
• Other Concentrations

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BASF SE
• Syngenta AG
• Corteva Agriscience
• FMC Corporation
• Bayer CropScience AG
• Adama Agricultural Solutions Ltd.
• UPL Limited
• Nufarm Limited
• Zhejiang Yongnong Chem. Ind. Co., Ltd.
• Hefei Great Chemical Group Co., Ltd.
• Shijiazhuang Wuyiling Chemical Co., Ltd.
• Jiangsu Tianrong Chemical Co., Ltd.
• Guangzhou Guanghua Chemical Co., Ltd.
• Wuhan Huazhong Chemical Co., Ltd.
• Shenzhen Jinhui Chemical Co., Ltd.